Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|February 26, 2008
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidemAndrea Cappelli, Germano Giuliani, Salvatore Valenti, et al.Journal of Medicinal Chemistry|April 29, 2005
1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitorsMariangela Biava, Giulio Cesare Porretta, Andrea Cappelli, et al.Journal of Medicinal Chemistry|May 13, 2005
Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory propertiesAndrea Cappelli, Andrea Gallelli, Monica Manini, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2013
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytesClaudia Sticozzi, Giuseppe Belmonte, Franco Cervellati, et al.Chemical Communications (Cambridge, England)|June 24, 2014
Dendrimeric tetravalent ligands for the serotonin-gated ion channelMarco Paolino, Laura Mennuni, Germano Giuliani, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 23, 2025
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylationValerio Ciccone, Claudia Cecchin, Maria Frosini, et al.Current Topics in Medicinal Chemistry|February 20, 2010
The interactions of the 5-HT3 receptor with quipazine-like arylpiperazine ligands: the journey track at the end of the first decade of the third millenniumAndrea Cappelli, Stefania Butini, Antonella Brizzi, et al.International Immunopharmacology|August 21, 2015
Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1βSara Cheleschi, Nicola Antonio Pascarelli, Giuseppe Valacchi, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Bivalent Ligands for the Serotonin 5-HT3 ReceptorAndrea Cappelli, Monica Manini, Marco Paolino, et al.Journal of Pharmacological Sciences|August 11, 2012
In vitro effects of VA441, a new selective cyclooxygenase-2 inhibitor, on human osteoarthritic chondrocytes exposed to IL-1βAntonella Fioravanti, Laura Tinti, Nicola Antonio Pascarelli, et al.Pageof 7